Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CBAY | RDY | SUPN | ||
| Company | Cymabay Therapeutics | Dr. Reddy's Laboratories Ltd ADR | Supernus Pharm | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 32.49 | 12.33 | 43.95 | ||
| High | 32.50 | 12.33 | 44.34 | ||
| Low | 32.48 | 12.12 | 43.12 | ||
| Last | 32.48 | 12.18 | 43.73 | ||
| Change | +0.01 | +0.02 | -0.46 | ||
| Percent Change | +0.03% | +0.16% | -1.04% | ||
| Volume | 8,356,200 | 1,674,200 | 487,900 | ||
| 20-Day Average Volume | 3,390,805 | 2,361,000 | 1,040,365 | ||
| Previous | 32.47 | 12.16 | 44.19 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 32.35 | 12.20 | 46.51 | ||
| 20-Day Raw Stochastic | 94.12% | 60.00% | 11.19% | ||
| 20-Day Relative Strength | 78.00 | 44.17 | 40.96 | ||
| Weighted Alpha | +247.60 | -16.96 | -8.76 | ||
| Today's Opinion | 100% Buy | 100% Sell | 100% Sell | ||
| Yesterday's Opinion | 100% Buy | 100% Sell | 100% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Sell | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.03% since 03/14/24 | unch since 08/21/26 | -4.62% since 08/21/26 | ||
| Low | 32.44 on 03/15/24 | 12.11 on 08/28/26 | 43.12 on 08/28/26 | ||
| High | 32.50 on 03/21/24 | 12.38 on 08/25/26 | 45.86 on 08/24/26 | ||
| 1-Month | |||||
| %Chg | +0.90% since 02/21/24 | +3.84% since 07/28/26 | -8.38% since 07/28/26 | ||
| Low | 32.15 on 02/22/24 | 11.58 on 08/10/26 | 42.63 on 08/04/26 | ||
| High | 32.50 on 03/21/24 | 12.58 on 08/11/26 | 52.50 on 08/03/26 | ||
| 3-Month | |||||
| %Chg | +46.17% since 12/21/23 | -9.91% since 05/28/26 | -6.66% since 05/28/26 | ||
| Low | 22.11 on 01/26/24 | 11.36 on 07/22/26 | 42.45 on 06/16/26 | ||
| High | 32.50 on 03/21/24 | 15.67 on 06/26/26 | 52.50 on 08/03/26 | ||
| 6-Month | |||||
| %Chg | +122.47% since 09/21/23 | -15.30% since 02/27/26 | -20.10% since 02/27/26 | ||
| Low | 12.32 on 10/13/23 | 11.36 on 07/22/26 | 42.45 on 06/16/26 | ||
| High | 32.50 on 03/21/24 | 15.67 on 06/26/26 | 56.49 on 03/04/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,726,235 | 10,166,244 | 2,541,893 | ||
| Shares Outstanding, K | 114,724 | 834,667 | 58,127 | ||
| Annual Sales, $M | 31,070,000 | 3,580,000,000 | 718,950,000 | ||
| Annual Net Income, $M | -105,370,000 | 456,000,000 | -38,550,000 | ||
| Last Qtr Sales, $M | 60,000 | 853,000,000 | 219,060,000 | ||
| Last Qtr Income, $M | -41,900,000 | 47,000,000 | -58,370,000 | ||
| 60-Month Beta | 0.32 | 0.29 | 0.56 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.35 on 02/28/24 | 0.06 on 07/22/26 | 0.54 on 08/03/26 | ||
| Latest Earnings Date | 05/20/24 | 10/23/26 | 11/03/26 | ||
| Most Recent Dividend | N/A | 0.064 on 07/24/26 | N/A | ||
| Next Ex-Dividend Date | N/A | 07/24/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.87 | 21.56 | ||